⏱ 1 min 30 read
Background
The Swiss Center for Electronics and Microtechnology (CSEM), based in Neuchâtel, transfers technology from research to industry. The Cicor Group, based in Boudry, specialises in printed circuit boards and the manufacture of electronic systems. The two Neuchâtel players aim to shorten the path from an innovative medical technology to series production.
The key points
On 11 November 2026, Cicor and CSEM announced a strategic, non-exclusive partnership. It is intended to accelerate the development of medical devices and wearable health technologies.
CSEM contributes its vital signs sensors and algorithms for health, wellness and sport. Cicor provides product development, industrialisation and the manufacture of complete medical devices. Products will be custom-designed according to customer requirements.
CSEM gives two examples, according to ArcInfo: a wristband that measures cardiovascular vital signs and a wearable therapeutic electrical stimulation device. Each development or manufacturing project will be covered by a separate agreement.
What it means for businesses
- Medtech companies : they gain an integrated path, from feasibility study and prototype to series production.
- Customers of both partners : the partnership aims to reduce development risks and time to market, according to Cicor.
Who says what
- Andreas Thomann (VP Engineering Services at Cicor): he believes manufacturing, reliability and scalability must be considered from the earliest stages of development.
- Josef Hayoz (Senior Manager Medtech at CSEM): he describes a more integrated path from technological innovation to products made at scale.
Further reading
Sources
- Cicor (I-Connect007) – Cicor, CSEM Partner to Accelerate Medical Device Innovation (official source)
- ArcInfo – Cicor and CSEM join forces to accelerate the production of medical devices
Let’s share Romandy’s news
We build the news together.
An idea, an opinion, a wish, a detail to add? Tell us!
